Showing results (181-190 of 244) with videos related to

Sort By:
Pageof 25
Thoracic Cancer|September 28, 2018
Impact of prolonged and early bevacizumab treatment on the overall survival of EGFR-mutant and EGFR-wild type nonsquamous non-small cell lung cancerYu-Chen Huang, Shih-Min Shen, Chien-Ying Liu, et al.
The Science of the Total Environment|May 8, 2019
Chronic obstructive pulmonary disease patients have a higher risk of occurrence of pneumonia by air pollutionShu-Chuan Ho, Kai-Jen Chuang, Kang-Yun Lee, et al.
The Science of the Total Environment|June 27, 2022
Climate-mediated air pollution associated with COPD severityHuan Minh Tran, Tzu-Tao Chen, Yueh-Hsun Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2016
NF-κB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistanceChing-Feng Chiu, Yi-Wen Chang, Kuang-Tai Kuo, et al.
Environmental Research|April 21, 2023
Impact of lifetime air pollution exposure patterns on the risk of chronic diseaseCheng-Yu Tsai, Chien-Ling Su, Yuan-Hung Wang, et al.
Annals of Medicine|December 3, 2024
Eosinophilic inflammation: a key player in COPD pathogenesis and progressionYueh-Lun Lee, Didik Setyo Heriyanto, Fara Silvia Yuliani, et al.
BMJ Open Respiratory Research|November 8, 2023
Association between air pollutant exposure, body water distribution and sleep disorder indices in individuals with low-arousal-threshold obstructive sleep apnoeaCheng-Yu Tsai, Ming Liu, Huei-Tyng Huang, et al.
Sensors (Basel, Switzerland)|December 10, 2021
Comparison of Hospital-Based and Home-Based Obstructive Sleep Apnoea Severity Measurements with a Single-Lead Electrocardiogram PatchWen-Te Liu, Shang-Yang Lin, Cheng-Yu Tsai, et al.
Investigational New Drugs|March 9, 2023
Evaluation of combination treatment with DS-1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer: results from a multicenter, open-label phase 1 studyJames Chih-Hsin Yang, Wu-Chou Su, Chao-Hua Chiu, et al.
Diagnostics (Basel, Switzerland)|May 14, 2025
Leveraging Subjective Parameters and Biomarkers in Machine Learning Models: The Feasibility of lnc-IL7R for Managing Emphysema ProgressionTzu-Tao Chen, Tzu-Yu Cheng, I-Jung Liu, et al.
Pageof 25